Key facts
- This page summarizes Daniel M. Junius's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 4 reported transactions and 3 derivative rows are listed below.
- Filing timestamp: 08 May 2025, 19:01.
Daniel M. Junius - 06 May 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Role
- Director
- Signature
- /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
- Issuer symbol
- IDXX
- Transactions as of
- 06 May 2025
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 08 May 2025, 19:01:05 UTC
- Previous filing
- 08 May 2024
- Next filing
- 14 May 2025
- SEC
- View on sec.gov
Key filing fact
Daniel M. Junius filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 08 May 2025.
Change
- Previous filing in this sequence was filed on 08 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001094159
Primary reporting owner
JUNIUS DANIEL M
- Relationship
- Director
- Address
- ONE IDEXX DRIVE, WESTBROOK
- Signature
- /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
- Signature date
- 08 May 2025
Transactions Table
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +262
- Change %
- +8.6%
- Price
- $0.000000
- Shares after
- 3,304
- Date
- 06 May 2025
- Ownership
- Direct
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -262
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 06 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 262
- Exercise price
- Footnotes
- F1
IDXX
transaction
Derivative
Non-Qualified Stock Option (right-to-buy)
Award
- Transaction value
- $0
- Shares
- +600
- Change %
- Price
- $0.000000
- Shares after
- 600
- Date
- 07 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 600
- Exercise price
- $486.61
- Footnotes
- F2
IDXX
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +257
- Change %
- Price
- $0.000000
- Shares after
- 257
- Date
- 07 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 257
- Exercise price
- Footnotes
- F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event was earlier. |
| F2 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event is earlier. |
| F3 | Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event earlier. |